Conmed Corp (CNMD) Live Share Price, Invest From India

Conmed Corp Stock Performance

as on October 31, 2025 at 1:29 am IST

Day's Low
Day's High
$44.28
Day's Price Range
$46.25
$44.51
0.52%
Downside
3.91%
Upside
52 Week's Low
52 Week's High
$42.5
52-Week Price Range
$78
$44.51
4.52%
Downside
75.24%
Upside

Conmed Corp share price movements today

Previous Close: $46.71
Open: $46.20
Volume: 548.4K
Day's Low - High: $44.28 - $46.25
52 Week Low - High: $42.5 - $78

Conmed Corp Historical Returns

1 Month Return: -5.66 %
3 Month Return: -13.02 %
1 Year Return: -34.8 %
3 Year Return: -44.2 %
5 Year Return: 0 %

Conmed Corp Stock Fundamentals & Key Indicators

Check Conmed Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

4.4678

Dividend Yield

1.08%

Quarterly Earnings Growth YOY

-0.28%

PE Ratio (TTM)

12.57

Industry PE ratio

8.355964912280701

PEG Ratio

5.29

EBITDA

220.1M

Revenue (TTM)

1.3B

Profit Margin

8.31%

Return On Equity TTM

11.69%

Conmed Corp Stock Valuation

Track how Conmed Corp P/E has moved over time to understand its valuation trends.

Conmed Corp in the last 5 years

Overview
Trends

Lowest (13.62x)

June 30, 2025

Industry (8.36x)

October 31, 2025

Today (12.57x)

October 31, 2025

Highest (45.55x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 12.57x

Conmed Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Conmed Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Conmed Corp	BUY	$1.4B	NA	12.57	8.31%
Boston Scientific Corp.	BUY	$148.6B	193.46%	53.64	14.43%
Stryker Corporation	BUY	$141.3B	82.65%	49.02	12.25%
Abbott Laboratories	BUY	$216.6B	18.61%	15.63	31.88%
Edwards Lifesciences Corp.	BUY	$49.0B	16.45%	34.93	72.96%

See all

Stock Returns calculator for Conmed Corp Stock including INR - Dollar returns

The Conmed Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Conmed Corp investment value today

Current value as on today

₹70,892

Returns

₹29,108

(-29.11%)

Returns from Conmed Corp Stock

₹34,774 (-34.77%)

Dollar Returns*

₹5,667 (+5.67%)

Analyst Recommendation on Conmed Corp Stock

Based on 14 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Conmed Corp. Average target price of $61

Conmed Corp Share Price Target

Get share price movements and forecasts by analysts on Conmed Corp.

What analysts predicted

27.03%UPSIDE

Target Price

$61

Current Price

$44.51

Analyzed by

14 Analysts

Target

$61.00

Conmed Corp target price $61, a slight upside of 27.03% compared to current price of $44.51. According to 14 analysts rating.

Conmed Corp Stock’s Investor Sentiment and Interest

Search interest for Conmed Corp Stock has increased by 80% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 1, 2025 to October 31, 2025

Change:80% versus previous 30 day period

Conmed Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	295	317	304	327	311	330	316	347	321	342
Gross Profit	155	170	168	184	161	173	178	200	177	188
Operating Income	-5	27	30	42	42	37	65	52	15	38
EBITDA	12	27	30	60	54	47	83	70	34	38
Interest Expense	10	9	10	9	9	9	9	8	8	7
Depreciation	17	18	17	18	18	17	17	18	18	18
Income Before Tax	2	17	20	40	25	37	56	43	7	29
Income Tax Expense	0	3	4	7	5	7	7	9	1	8
Net Income	1	13	15	33	19	29	48	33	6	21
Net Profit Margin	0.62%	4.32%	5.20%	10.11%	6.32%	9.06%	15.47%	9.70%	1.88%	6.26%

Conmed Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	719	763	796	859	955	862	1,010	1,045	1,244	1,307
Gross Profit	381	408	431	469	524	460	568	571	676	733
Operating Income	51	37	46	71	1	-26	37	70	130	200
EBITDA	95	90	105	133	124	113	158	7	192	272
Interest Expense	6	15	18	20	42	44	35	28	39	37
Depreciation	-	-	58	61	72	72	70	69	71	71
Income Before Tax	45	19	28	50	31	1	73	-70	80	163
Income Tax Expense	14	4	-26	9	2	-7	10	9	16	30
Net Income	30	14	55	40	28	9	62	-80	64	132
Net Profit Margin	4.24%	1.92%	6.97%	4.75%	3.00%	1.10%	6.19%	-7.71%	5.18%	10.13%

Conmed Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	13	15	33	19	29	48	33	6	21
Operating Cash Flow	26	46	56	29	43	51	43	41	29
Investing Cash Flow	-5	-5	-4	-2	-3	-3	-4	-2	-5
Financing Cash Flow	-19	-37	-58	-17	-44	-38	-51	-28	-26
Change in Cash	1	2	-6	9	-4	9	-14	11	-1

Conmed Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	14	55	40	28	9	62	-80	64	132
Operating Cash Flow	38	65	74	95	64	111	33	125	166
Investing Cash Flow	-266	-29	-16	-387	-13	-14	-249	-20	-13
Financing Cash Flow	184	-34	-72	300	-52	-101	225	-110	-151
Change in Cash	-45	5	-15	8	1	-6	8	-4	0

Global Institutional Holdings in Conmed Corp

Funds	Holdings
BlackRock Inc	15.61%
Vanguard Group Inc	11.46%
Earnest Partners LLC	9.14%
Fuller & Thaler Asset Management Inc	5.62%
Capital Research Global Investors	5.41%

See all

Insights on Conmed Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 6.03M → 21.42M (in $), with an average increase of 71.8% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 321.25M → 342.34M (in $), with an average increase of 6.2% per quarter
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 24.6% return, outperforming this stock by 59.4%
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 15.3% return, outperforming this stock by 59.5%
NEGATIVE IMPACT
Price Dip
In the last 1 year, CNMD stock has moved down by -34.8%

About Conmed Corp

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500

Organisation	Conmed Corp
Headquarters	11311 Concept Boulevard, Largo, FL, United States, 33773-4908
Industry	Health Technology
CEO	Mr. Patrick J. Beyer
E-voting on shares	Click here to vote

Key Management of Conmed Corp

Name	Title
Mr. Andrew Moller	Principal Accounting Officer, VP & Corporate Controller
Mr. Richard Glaze	Chief Information Officer
Ms. Shanna L. Cotti-Osmanski	Executive VP of Information Technology & CIO
Mr. John Ferrell	Executive Vice President of Human Resources
Mr. Patrick J. Beyer	President, CEO & Director
Mr. Todd W. Garner CPA	Executive VP of Finance & CFO
Mr. Peter K. Shagory	Executive Vice President of Strategy & Corporate Development
Mr. Curt R. Hartman	Special Advisor
Mr. Brent Lalomia	Executive VP of Regulatory Affairs, Quality Assurance, Clinical Affairs, & Commercial Operations
Ms. Hollie K. Foust	Executive VP, General Counsel and Corporate Secretary

FAQs

What is Conmed Corp share price today?

Conmed Corp share price today is $44.51 as on October 31, 2025 at 1:29 am IST at the close of the market. Conmed Corp share today touched a day high of $46.25 and a low of $44.28.

What is the 52 week high and 52 week low for Conmed Corp share?

Conmed Corp share touched a 52 week high of $78 on November 25, 2024 and a 52 week low of $42.5 on October 10, 2025. Conmed Corp stock price today i.e. October 31, 2025 at 1:29 am IST is closed at $44.51,which is 42.94% down from its 52 week high and 4.73% up from its 52 week low.

What is Conmed Corp's market capitalisation today?

Conmed Corp market capitalisation is $0.00T as on October 31, 2025 at 1:29 am IST.

How to invest in Conmed Corp Stock (CNMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Conmed Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Conmed Corp Shares that will get you 0.0337 shares as per Conmed Corp share price of $44.51 per share as on October 31, 2025 at 1:29 am IST.

What is the minimum amount required to buy Conmed Corp Stock (CNMD) from India?

Indian investors can start investing in Conmed Corp (CNMD) shares with as little as ₹88.686 or $1 (as of October 31, 2025 at 1:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Conmed Corp stock (as per the Rupee-Dollar exchange rate as on October 31, 2025 at 1:43 pm IST). Based on Conmed Corp share’s latest price of $44.51 as on October 31, 2025 at 1:29 am IST, you will get 0.2247 shares of Conmed Corp. Learn more about fractional shares .